We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Momenta Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 211 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 211 → 0 (-211)

100% less funds holding in top 10

Funds holding in top 10: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $5.44B → $0 (-$5.44B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 211

Holders
–
Holders Change
-211
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
211
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.01B
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$685M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$622M
4
HI
HBK Investments
Texas
-$257M
5
State Street
State Street
Massachusetts
-$238M
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
151
Zurich Cantonal Bank
Switzerland
– -$709K -13,506 Closed
KPF
152
K2 Principal Fund
Ontario, Canada
– -$656K -12,500 Closed
Natixis Advisors
153
Natixis Advisors
Massachusetts
– -$640K -12,189 Closed
SEC
154
Seven Eight Capital
New York
– -$631K -12,020 Closed
Jennison Associates
155
Jennison Associates
New York
– -$583K -11,116 Closed
MCI
156
McDonald Capital Investors
California
– -$583K -11,100 Closed
CGH
157
Crossmark Global Holdings
Texas
– -$562K -10,700 Closed
SCS
158
Syquant Capital SAS
France
– -$562K -10,700 Closed
AIP
159
Ameritas Investment Partners
Nebraska
– -$527K -10,046 Closed
CCM
160
Crabel Capital Management
California
– -$503K -9,588 Closed
VF
161
Virtu Financial
New York
– -$502K -9,562 Closed
FFA
162
Fragasso Financial Advisors
Pennsylvania
– -$472K -9,000 Closed
Allianz Asset Management
163
Allianz Asset Management
Germany
– -$458K -8,734 Closed
Bank of Montreal
164
Bank of Montreal
Ontario, Canada
– -$442K -8,429 Closed
SCM
165
Shelton Capital Management
Colorado
– -$427K -8,132 Closed
Verition Fund Management
166
Verition Fund Management
Connecticut
– -$405K -7,725 Closed
BAM
167
Blueshift Asset Management
New Jersey
– -$389K -7,420 Closed
PAG
168
Private Advisor Group
New Jersey
– -$376K -7,165 Closed
PNC Financial Services Group
169
PNC Financial Services Group
Pennsylvania
– -$340K -6,486 Closed
Teacher Retirement System of Texas
170
Teacher Retirement System of Texas
Texas
– -$336K -6,404 Closed
CI Investments Inc
171
CI Investments Inc
Ontario, Canada
– -$324K -6,174 Closed
FCBT
172
First Citizens Bank & Trust
North Carolina
– -$314K -5,988 Closed
Envestnet Asset Management
173
Envestnet Asset Management
Illinois
– -$308K -5,864 Closed
VCM
174
Vivaldi Capital Management
Illinois
– -$288K -5,489 Closed
JCM
175
JS Capital Management
New York
– -$268K -5,100 Closed
5 6
7
8 9

MNTA Hedge Fund Activity: Q4 2020 in Review

0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2020, worth a combined $0 — down 100% from $5.44B a quarter earlier.

Sellers outnumbered buyers: 211 funds closed out of MNTA and 0 opened new positions — a net loss of 211 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $1.01B sold.

  • 0 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2020, down from 211 in Q3 2020.
  • Funds reported $0 of Momenta Pharmaceuticals, Inc. stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2020 and 211 closed out, a net change of -211 holders.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q4 2020 was BlackRock, an estimated $1.01B sold.

Based on aggregated 13F filings for Q4 2020.